The dopamine transporter (DAT) belongs to the neurotransmitter:sodium symporter (NSS) family of membrane proteins that are responsible for reuptake of neurotransmitters from the synaptic cleft to terminate a neuronal signal and enable subsequent neurotransmitter release from the presynaptic neuron. The release of one sodium ion from the crystallographically determined sodium binding site Na2 had been identified as an initial step in the transport cycle which prepares the transporter for substrate translocation by stabilizing an inward-open conformation. We have constructed Markov State Models (MSMs) from extensive molecular dynamics simulations of human DAT (hDAT) to explore the mechanism of this sodium release. Our results quantify the release process triggered by hydration of the Na2 site that occurs concomitantly with a conformational transition from an outward-facing to an inward-facing state of the transporter. The kinetics of the release process are computed from the MSM, and transition path theory is used to identify the most probable sodium release pathways. An intermediate state is discovered on the sodium release pathway, and the results reveal the importance of various modes of interaction of the N-terminus of hDAT in controlling the pathways of release.The dopamine transporter (DAT) is a transmembrane (TM) secondary transporter protein belonging to the Neurotransmitter:Sodium Symporter (NSS) family, which also includes the closely related serotonin (SERT) and norepinephrine (NET) transporters 1 . The NSS are responsible for clearance of released neurotransmitters (e.g. dopamine (DA), by DAT) from the synaptic cleft through their translocation back into the presynaptic nerve termini. The function of NSS transporters in neuronal signaling implicate them in the mechanisms of action of abused psychostimulants, such as cocaine and amphetamine 2,3 , and in various psychiatric and neurological disorders including drug addiction, schizophrenia, and Parkinson's disease 3 . These essential neurophysiological roles have made NSS transporters primary targets for antidepressant medications.Breakthrough crystallographic determinations of members of the NSS family includes the bacterial homolog LeuT 4,5 , and most recently the structures of Drosophila DAT (dDAT) [6][7][8] . Structures of these transporters have been determined in complex with various substrates and ligands in the primary (S1) and secondary (S2) binding sites and with sodium ions bound in sites Na1 and Na2. They have offered an essential molecular context for the investigation of the mechanism of uphill neurotransmitter reuptake transport enabled by the coupling with the transmembrane Na + gradient 1,10 . Our current understanding of functional mechanisms in NSS has been further shaped by the large body of structure-function studies of LeuT and other related bacterial transporters, carried out both experimentally 11-17 and computationally [11][12][13][14]16,[18][19][20][21][22][23] , and more recently by findings from molecular dynamics (MD) simulat...